Morphologic changes of mammary carcinomas in mice over time as monitored by flat-panel detector volume computed tomography

Neoplasia

Volumn 10, Issue 7, 2008, Pages 663-673

  Missbach Guentner, Jeannine ^a,b   Dullin, Christian ^a   Kimmina, Sarah ^a   Zientkowska, Marta ^a   Domeyer Missbach, Melanie ^a   Malz, Cordula ^a   Grabbe, Eckhardt ^a   Stühmer, Walter ^b   Alves, Frauke ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; DISEASE COURSE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIODENSITOMETRY; SCID MOUSE; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 45849090257     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08270     Document Type: Article

References (41)

1. Somville J, De Beuckeleer L, De Schepper A, Verstreken J, and Taminiau A (2001). Reliability of measuring volume by different methods for tumors of the musculoskeletal system. Acta Orthop Belg 67, 338-343.
2. Schmidt KF, Ziu M, Schmidt NO, Vaghasia P, Cargioli TG, Doshi S, Albert MS, Black PM, Carroll RS, and Sun Y (2004). Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. J Neurooncol 68, 207-215.
3. McCarville MB, Streck CJ, Dickson PV, Li CS, Nathwani AC, and Davidoff AM (2006). Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced grey-scale US. Radiology 240, 73-81.
4. Wu G, Wang L, Yu L, Wang H, and Xuan JW (2005). The use of three-dimensional ultrasound micro-imaging to monitor prostate tumor development in a transgenic prostate cancer mouse model. Tohoku J Exp Med 207, 181-189.
5. Wirtzfeld LA, Wu G, Bygrave M, Yamasaki Y, Sakai H, Moussa M, Izawa JI, Downey DB, Greenberg NM, Fenster A, et al. (2005). A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model. Cancer Res 65, 5231-5237.
6. Krneta J, Kroll J, Alves F, Prahst C, Sananbenesi F, Dullin C, Kimmina S, Phillips DJ, and Augustin HG (2006). Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors. Cancer Res 66, 5686-5695.
7. Cavanough D, Johnson E, Price RE, Kurie J, Travis EL, and Cody DD (2004). In vivo respiratory-gated micro-CT imaging in small animal oncology models. Mol Imaging 3, 55-62.
8. Yang Y, Tai YC, Siegel S, Newport DF, Bai B, Li Q, Leahy RM, and Cherry SR (2004). Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging. Phys Med Biol 49, 2527-2545.
9. Del Guerra A and Belcari N (2002). Advances in animal PET scanners. Q J Nucl Med 46, 35-47.
10. Greschus S, Kiessling F, Lichy MP, Moll J, Mueller MM, Savai R, Rose F, Ruppert C, Günther A, Luecke M, et al. (2005). Potential applications of flat-panel volumetric CT in morphological and functional small animal imaging. Neoplasia 7, 730-740.
11. Kiessling F, Greschus S, Lichy MP, Bock M, Fink C, Vosseler S, Moll J, Mueller MM, Fusenig NE, Traupe H, et al. (2005). Volumetric computed tomography (VCT): a new technology for non-invasive, high-resolution monitoring of tumor angiogenesis. Nat Med 10, 1133-1138.
12. Dullin C, Missbach-Guentner J, Vogel WF, Grabbe E, and Alves F (2007). Semi-automatic classification of skeletal morphology in genetically altered mice using flat-panel volume computed tomography. PloS Genet 3, e118.
13. Obenauer S, Dullin C, Alves F, Missbach-Guentner J, Grabbe E, and Heuser M (2007). Flat-panel-detector-based volumetric CT: performance evaluation of imaging for skeletal structures of small animals in comparison to multislice CT. Clin Imaging 31, 18-22.
14. Obert M, Ahlemeyer B, Baumgart-Vogt E, and Traupe H (2005). Flat-panel volumetric computed tomography: a new method for visualizing fine bone detail in living mice. J Comput Assist Tomogr 29, 560-565.
15. Missbach-Guentner J, Dullin C, Zientkowska M, Domeyer-Missbach M, Kimmina S, Obenauer S, Kauer F, Stühmer W, Grabbe E, Vogel WF, et al. (2007). Flat-panel detector based fpVCT: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model. Neoplasia 9, 755-765.
16. Tomayko MM and Reynolds CP (1989). Determination of subcutaneous tumor size in athymic nude mice. Cancer Chemother Pharmacol 24, 148-154.
17. Dullin C (2001). Entwicklung einer Methode zur Segmentierung verschiedener Strukturen im Datenmaterial bildgebender Messverfahren in der Medizin [diploma thesis]. Jena, Germany: Friedrich-Schiller Universität.
18. Rygaard K and Spang-Thomsen M (1997). Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Res Treat 46, 303-312.
19. Reynolds CP, Sun BC, DeClerck YA, and Moats RA (2005). In Methods in Molecular Medicine, Vol. 111: Chemosensitivity: Vol. 2: In vivo Models, Imaging, and Molecular Regulators. RD Blumenthal (Ed.). Totowa, NJ: Humana Press, pp. 335-350.
20. Spang-Thomsen M, Nielsen A, and Visfeldt J (1980). Growth curves of three human malignant tumors transplanted to nude mice. Exp Cell Biol 48, 138-154.
21. Engelke K, Karolczak M, Lutz A, Seibert U, Schaller S, and Kalender W (1999). Micro-CT. Technology and application for assessing bone structure [in German]. Radiologe 39, 203-212.
22. Ford NL, Thornton MM, and Holdsworth DW (2003). Fundamental image quality limits for microcomputed tomography in small animals. Med Phys 30, 2869-2877.
23. Taschereau R, Chow PL, and Chatziionnaou AF (2006). Monte Carlo simulations of dose from microCT imaging procedures in a realistic mouse phantom. Med Phys 33, 216-224.
24. Cline HE, Dumoulin CL, Hart HR, Lorensen WE, and Ludke S (1987). 3D reconstruction of the brain from magnetic resonance images using a connectivity algorithm. Magn Reson Imaging 5, 345-352.
25. Vaidyanathan M, Clarke LP, Hall LO, Heidtman C, Velthuizen R, Gosche K, Phuphanich S, Wagner H, Greenberg H, and Silbiger ML (1997). Monitoring brain tumor response to therapy using MRI segmentation. Magn Reson Imaging 15, 323-334.
26. Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, and Hoffman RM (2005). High correlation of whole body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Res 65, 9829-9833.
27. Krishna MC, Subramanian S, Kuppusamy P, and Mitchell JB (2001). Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration. Semin Radiat Oncol 11, 58-69.
28. Williams BB, al Hallaq H, Chandramouli GV, Barth ED, Rivers JN, Lewis M, Galtsev VE, Karczmar GS, and Halpern HJ (2002). Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI. Magn Reson Med 47, 634-638.
29. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, and Solaiyappan M (2001). Vascular differences detected by MRI for metastatic versus non-metastatic breast and prostate cancer xenografts. Neoplasia 3, 143-153.
30. Blankenberg FG, Eckelman WC, Strauss HW, Welch MJ, Alavi A, Anderson C, Bacharach S, Blasberg RG, Graham MM, and Weber W (2000). Role of radionuclide imaging in trials of antiangiogenic therapy. Acad Radiol 7, 851-867.
31. Padhani AR and Neeman M (2001). Challenges for imaging angiogenesis. Br J Radiol 74, 886-890.
32. Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res 49, 6449-6465.
33. Savai R, Wolf JC, Greschus S, Eul BG, Schermuly RT, Hänze J, Voswinckel R, Langheinrich AC, Grimminger F, Traupe H, et al. (2005). Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography. Am J Pathol 167, 937-946.
34. Jain RK (1990). Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9, 253-266.
35. Purdie TG, Lee TY, Iizuka M, and Sherar MD (2000). Dynamic contrast enhanced CT measurement of blood flow during interstitial laser photocoagulation: comparison with an Arrhenius damage model. Phys Med Biol 45, 1115-1126.
36. Eastwood JD, Lev MH, Azhari T, Lee TY, Barboriak DP, Delong DM, Fitzek C, Herzau M, Wintermark M, Meuli R, et al. (2002). CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 222, 227-236.
37. Wiart M, Corot C, Berthezene Y, Violas X, and Canet E (2001). CT pulmonary angiography with a macromolecular contrast medium: a comparative study versus iobitridol in rabbits. Invest Radiol 36, 547-553.
38. Idee JM, Port M, Robert P, Raynal I, Prigent P, Dencausse A, Le Greneur S, Tichkowsky I, Le Lem G, Bourrinet P, et al. (2001). Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743. Invest Radiol 36, 41-49.
39. McDonald DM and Choyke PL (2003). Imaging of angiogenesis: from microscope to clinic. Nat Med 9, 713-725.
40. Fox SB (1997). Tumour angiogenesis and prognosis. Histopathology 30, 294-301.
41. Augustin HG (2001). Tubes, branches and pillars. The many ways of forming new vasculature. Circ Res 89, 645-647.